Edition:
United Kingdom

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

3.97USD
15 Feb 2019
Change (% chg)

$0.07 (+1.79%)
Prev Close
$3.90
Open
$3.93
Day's High
$3.97
Day's Low
$3.90
Volume
62,274
Avg. Vol
85,623
52-wk High
$17.39
52-wk Low
$3.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.31 -0.208
Jun '18 2.03 -0.194
Mar '18 1.46 -0.202
FY 2017 Dec '17 16.42 0.073
Sep '17 1.07 -0.154
Jun '17 0.75 -0.216
Mar '17 2.01 -0.166
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 82.37 82.37 82.37 --
Quarter Ending Jun-19 1 2.03 2.03 2.03 --
Year Ending Dec-19 4 74.08 148.67 6.93 10.02
Earnings (per share)
Quarter Ending Mar-19 1 1.01 1.01 1.01 --
Quarter Ending Jun-19 1 -0.18 -0.18 -0.18 --
Year Ending Dec-19 4 0.09 1.35 -0.96 -1.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -- 1.08 0.90
Price to Sales (TTM) 113.23 49.51 6.29
Price to Book (MRQ) 5.17 10.14 5.26
Price to Tangible Book (MRQ) 5.17 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 18.18 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.23 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -87.77 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -190.05 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -263.41 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 21.60 3.50 3.08
LT Debt to Equity (MRQ) 0.32 18.65 11.38
Total Debt to Equity (MRQ) 0.32 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -594.80 -- --
EBITD - 5 Yr. Avg -- -110.40 12.87
Operating Margin (TTM) -601.68 -184.63 6.20
Operating Margin - 5 Yr. Avg. -- -126.89 8.31
Pre-Tax Margin (TTM) -645.62 -175.33 7.16
Pre-Tax Margin - 5 Yr. Avg. -- -132.68 8.61
Net Profit Margin (TTM) -645.62 -182.03 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.07 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 84,281 7,654,601 842,398,385
Net Income/Employee (TTM) -544,130 562,114 99,842,801
Receivable Turnover (TTM) 8.62 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.05 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -32.55 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -33.72 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -40.61 39.04 --
EPS (TTM) % -137.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AC Immune SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 19.53 15.41 81 99
13 Week 31.08 24.70 81 95
26 Week 11.71 3.21 64 98
52 Week -29.98 -40.65 30 72
YTD -13.25 -23.82 32 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.21%
# of Holders: 51
Total Shares Held: 21,338,591
3 Mo. Net Change: 1,178,577
# New Positions: 20
# Closed Positions: 7
# Increased Positions: 29
# Reduced Positions: 18
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.